ERBB2 c.1383G>A ;(p.L461=)

Variant ID: 17-37872062-G-A

NM_004448.2(ERBB2):c.1383G>A;(p.L461=)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells.

Npj Systems Biology And Applications
Immanuel, Selva Rupa Christinal SRC; Ghanate, Avinash D AD; Parmar, Dharmeshkumar S DS; Yadav, Ritu R; Uthup, Riya R; Panchagnula, Venkateswarlu V; Raghunathan, Anu A
Publication Date: 2021-01-08

Variant appearance in text: ERBB2: L461L
PubMed Link: 33420045
Variant Present in the following documents:
  • 41540_2020_161_MOESM3_ESM.xlsx, sheet 2
  • 41540_2020_161_MOESM3_ESM.xlsx, sheet 3
View BVdb publication page



Human In Vitro Models for Assessing the Genomic Basis of Chemotherapy-Induced Cardiovascular Toxicity.

Journal Of Cardiovascular Translational Research
Pinheiro, Emily A EA; Magdy, Tarek T; Burridge, Paul W PW
Publication Date: 2020-06

Variant appearance in text: HER2: L461L
PubMed Link: 32078739
Variant Present in the following documents:
  • Main text
View BVdb publication page